Re-Establishing Greatness: Scherzer, Buehler’s…

Three years ago, the results of voting for 2021’s NL Cy Young award were announced. The top of the ballot featured a somewhat controversial battle between the elite rate production of then-Brewers ace Corbin Burnes and the volume offered by Phillies ace Zack Wheeler, with Burnes ultimately taking home the trophy. Finish just below them in balloting, however, was a pair of hurlers from the playoff rotation that took the Dodgers to the NLCS: right-handers Max Scherzer and Walker Buehler.

Flash forward three years, and things have gone quite well for the first- and second-place finishers for that year’s Cy Young in the NL. Burnes enters this winter as the consensus top free-agent pitcher available and could be in line for a guarantee that reaches $200M, while Wheeler opted against returning to the open market in favor of extending with the Phillies on a three-year, $126M contract earlier this year and now stands as a Cy Young finalist once again alongside Chris Sale and Paul Skenes. Scherzer and Buehler are also headed into free agency this winter, although neither figures to be in line for a nine-figure guarantee like those of Burnes and Wheeler.

Instead, both hurlers figure to enter the open market hoping to re-establish themselves as front-of-the-rotation talents after facing adversity in recent years. Scherzer and Buehler landed the 33rd and 37th spots on MLBTR’s annual Top 50 MLB Free Agents list this winter, as we predicted one-year deals worth $16M and $15M, respectively, for each player. While both hurlers boast ace-level pedigrees and could wind up signing similar contracts this winter, the pair took different paths to get to this point over recent years, and their unique challenges and assets could inform the preferences of prospective suitors.

Scherzer’s struggles in recent seasons have been almost entirely about health rather than performance. After turning in 11 utterly dominant starts for the Dodgers down the stretch following a trade from the Nationals at that summer’s trade deadline, the veteran right-hander’s season came to an abrupt end when he was forced out of Game 2 of the NLCS due to a dead arm after just 4 1/3 innings of work. Scherzer was unable to bounce-back in time to pitch again for L.A. in that series and ultimately departed the club on the heels of their loss to the eventual World Champion Braves in the series.

After landing with the Mets on a three-year guarantee worth $130M, Scherzer turned in a dominant 2022 campaign for New York but was limited to just 23 starts due to oblique issues. It was the fewest starts he had made in a full season during his career, and his 145 1/3 innings of work, while hardly out of the ordinary for a starter in recent years, was similarly a full-season career low. The right-hander bounced back in terms of volume in 2023, making 27 starts for the Mets and Rangers throughout the regular season, but suffered on the performance front as he posted a somewhat middling 3.77 ERA (112 ERA+) in 152 2/3 innings of work. Those results improved significantly (3.20 ERA, 135 ERA+) down the stretch following his trade to Texas, but much like 2021, Scherzer struggled with injuries late in the season and was hampered during the playoffs, ultimately pitching just 9 2/3 innings total during the club’s championship run.

While Scherzer’s declining volume and production were somewhat concerning, the future Hall of Famer was still clearly among the top pitchers in the sport even as he began to struggle with injury. Over those aforementioned two seasons, Scherzer combined for 50 starts where he posted an excellent 3.03 ERA (133 ERA+) with a 3.49 FIP and a 29.3% strikeout rate in 298 innings of work. That performance was good for 6.7 fWAR, good for 23rd among all starters across those two seasons and sandwiched between the likes of Max Fried and Clayton Kershaw.

Unfortunately for the veteran, however, things took a substantial turn for the worse in 2024 as he suffered from the first truly injury-plagued season of his career. After undergoing back surgery last offseason, Scherzer’s was expected to miss at least the first couple of months of action. That timetable was further delayed by nerve issues, and by the time shoulder fatigue brought his season to an early end in September, he had made just nine total starts this season. Those nine starts saw Scherzer pitch effectively, though not close to the ace-level production he had flashed even two years prior. In 43 1/3 innings of work this season, he pitched to a 3.95 ERA with a 4.18 FIP, striking out 22.6% of opponents faced while walking just 5.6%.

Looking ahead to 2025, it’s certainly easy to imagine Scherzer providing high-quality production whenever he’s on the field, given the league-average results he posted while fighting through injury this year and his pedigree as a three-time winner and six-time finalist of the Cy Young award. With that being said, the veteran will celebrate his 41st birthday in July of 2025, and his increasingly detrimental injury woes in recent years leave plenty of questions about just how many starts Scherzer can be counted on for in 2025, particularly in the postseason given the injury questions he faced in 2023, 2021, and even 2019 with the Nationals.

By contrast, Buehler comes with far fewer questions regarding his overall health. That’s to be expected from a player who is a decade and a day Scherzer’s junior. That’s not to say Buehler hasn’t had health issues of his own, of course, as Buehler had nearly two full calendar years of his career wiped out by Tommy John surgery. Buehler returned to the mound for the Dodgers on May 7 of this year after having last pitched in a major league game on June 10 of 2022. The righty has had few injury woes throughout his career aside from his two career elbow surgeries, with a bout of hip inflammation this year and a rib injury back in 2018 representing the only other significant injuries of his big league career.

With that being said, it’s worth noting that the aforementioned Tommy John surgery was actually the second of Buehler’s pitching career. It’s not uncommon for players to struggle after going under the knife a second time, though some pitchers such as Nathan Eovaldi and Jameson Taillon have undergone the procedure twice and gone on to be effective for years following their second surgery. Buehler also averaged 95 mph on his fastball in 2024, an encouraging sign as it’s right in line with his average prior to going under the knife.

That’s not to say Buehler lacks question marks, however. The right-hander’s 2024 season was nothing short of atrocious. He surrendered a 5.38 ERA and 5.54 FIP that were both more than 30% worse than league average by ERA- and FIP-, while his 18.6% strikeout rate and 8.1% walk rate were both the worst marks of his career since he became a full-time player in 2018. While Buehler’s solid 15 innings of work during the playoffs (3.60 ERA, 3.50 FIP) offer some reason for optimism, particularly as he struck out a third of his opponents in the NLCS and World Series, his atrocious regular-season results are difficult to ignore. While Scherzer seems to be a reasonable bet to produce when healthy enough to take the mound, Buehler will need to improve his overall production substantially to be an even league-average starter next year even as he flashed his front-of-the-rotation upside late in the Dodgers’ championship run this postseason.